Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

INGN

Inogen Inc

Nov 03 • 04:00PM ET

8.21

-0.03 -0.36 %

Healthcare • Medical Devices • USA • NASD

Peers: RMD ABT ISRG BSX PHG BDX GEHC MDT ZBH AAPL

| Held by: VTI IWM VXF IWN DFAT VTWO DFAS IWC AVSC PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.06	Insider Own	13.94%	Shs Outstand	27.04M	Perf Week	-5.20%
Market Cap	222.00M	Forward P/E	-	EPS next Y	-0.78	Insider Trans	0.00%	Shs Float	23.27M	Perf Month	-5.09%
Enterprise Value	117.34M	PEG	-	EPS next Q	-0.22	Inst Own	73.03%	Short Float	3.15%	Perf Quarter	29.70%
Income	-26.05M	P/S	0.65	EPS this Y	36.51%	Inst Trans	3.42%	Short Ratio	3.53	Perf Half Y	17.79%
Sales	343.47M	P/B	1.11	EPS next Y	19.17%	ROA	-8.39%	Short Interest	0.73M	Perf YTD	-10.47%
Book/sh	7.38	P/C	1.79	EPS next 5Y	25.44%	ROE	-13.46%	52W High	12.91 -36.41%	Perf Year	-11.43%
Cash/sh	4.57	P/FCF	-	EPS past 3/5Y	-75.31% -	ROIC	-12.09%	52W Low	5.70 44.04%	Perf 3Y	-63.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.12% -1.49%	Gross Margin	49.89%	Volatility	3.63% 4.16%	Perf 5Y	-71.52%
Dividend TTM	-	EV/Sales	0.34	EPS Y/Y TTM	73.29%	Oper. Margin	-9.03%	ATR (14)	0.33	Perf 10Y	-79.79%
Dividend Ex-Date	-	Quick Ratio	2.67	Sales Y/Y TTM	5.15%	Profit Margin	-7.58%	RSI (14)	44.66	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.03	EPS Q/Q	34.94%	SMA20	-3.19%	Beta	1.84	Target Price	13.00
Payout	-	Debt/Eq	0.10	Sales Q/Q	3.96%	SMA50	-2.04%	Rel Volume	1.00	Prev Close	8.24
Employees	766	LT Debt/Eq	0.08	Earnings	Nov 05 BMO	SMA200	4.86%	Avg Volume	207.32K	Price	8.21
IPO	Feb 14, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.76% 1.85%	Trades		Volume	206,828	Change	-0.36%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	B. Riley Securities	Buy	$14
May-22-25	Upgrade	Needham	Hold → Buy	$12
Feb-15-24	Upgrade	William Blair	Mkt Perform → Outperform
Aug-08-23	Downgrade	JP Morgan	Overweight → Neutral	$15 → $8
Jul-14-23	Downgrade	Needham	Buy → Hold
Jan-17-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-09-21	Upgrade	Needham	Hold → Buy	$47
Nov-02-21	Upgrade	JP Morgan	Underweight → Neutral	$45
Aug-05-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-04-21	Upgrade	William Blair	Mkt Perform → Outperform
Dec-14-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$60
Jul-23-20	Downgrade	Needham	Buy → Hold
May-06-20	Reiterated	Needham	Buy	$80 → $75
Nov-06-19	Upgrade	Needham	Hold → Buy	$90
Sep-13-19	Reiterated	Piper Jaffray	Overweight	$80 → $80
Aug-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$78 → $47
Aug-08-19	Downgrade	Stifel	Buy → Hold
Aug-07-19	Downgrade	Needham	Buy → Hold
Jun-28-19	Downgrade	Needham	Strong Buy → Buy	$111 → $91
May-08-19	Reiterated	Needham	Strong Buy	$191 → $111

Show Previous Ratings

Oct-15-25 08:30AM	Inogen to Report Third Quarter 2025 Financial Results on November 5, 2025 (Business Wire)
Sep-30-25 08:50AM	Why Fast-paced Mover Inogen (INGN) Is a Great Choice for Value Investors (Zacks)
Sep-26-25 09:21AM	GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent (Zacks)
Sep-25-25 04:05PM	Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer (Business Wire)
09:24AM	Masimo Completes Divestment of Consumer Audio Business to HARMAN (Zacks)
08:21AM	Loading…
Sep-23-25 08:21AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Sep-11-25 08:24AM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Sep-08-25 05:04PM	Wall Street Analysts See a 35.64% Upside in Inogen (INGN): Can the Stock Really Move This High? (Zacks)
Sep-02-25 10:36AM	3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI (Zacks)
Aug-21-25 09:55AM	Wall Street Analysts Think Inogen (INGN) Could Surge 49.25%: Read This Before Placing a Bet (Zacks)
Aug-12-25 04:42AM	US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 \| Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD (GlobeNewswire) +7.67%
Aug-08-25 12:11PM	Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y (Zacks) +10.39%
03:40AM	Inogen Inc (INGN) Q2 2025 Earnings Call Highlights: Steady Growth Amidst Challenges (GuruFocus.com)
Aug-07-25 06:55PM	Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -6.83%
06:08PM	Inogen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Inogen Announces Second Quarter 2025 Financial Results (Business Wire)
Aug-05-25 06:50PM	Masimo (MASI) Beats Q2 Earnings and Revenue Estimates (Zacks)
Jul-17-25 08:30AM	Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
Jul-16-25 09:42AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
Jun-23-25 08:30AM	Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy (Business Wire)
Jun-06-25 11:31AM	Inogen (INGN) Down 0.8% Since Last Earnings Report: Can It Rebound? (Zacks)
May-28-25 09:14AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
04:41AM	Zacks.com featured highlights Urban Outfitters, Inogen and Southwest Gas (Zacks)
May-27-25 09:10AM	3 Stocks With Upgraded Broker Ratings to Bet on Amid Uncertainties (Zacks)
May-22-25 04:34PM	Needham Upgrades Inogen (INGN) to Buy (Insider Monkey) +13.26%
May-16-25 12:00PM	What Makes Inogen (INGN) a New Buy Stock (Zacks) +5.91%
09:35AM	After Plunging -15.69% in 4 Weeks, Here's Why the Trend Might Reverse for Inogen (INGN) (Zacks)
May-08-25 12:06PM	INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y (Zacks) -11.44%
03:36AM	Inogen Inc (INGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... (GuruFocus.com)
May-07-25 08:18PM	Inogen targets $352M-$355M in 2025 revenue with focus on B2B growth and strategic innovations (Seeking Alpha)
08:16PM	Loading…
08:16PM	Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:00PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings (Zacks)
05:55PM	Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:53PM	Inogen: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces First Quarter 2025 Financial Results (Business Wire)
10:00AM	Here are the major earnings after the close today (Seeking Alpha)
May-06-25 10:13AM	MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN (Zacks)
May-01-25 05:45PM	Mettler-Toledo (MTD) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-16-25 08:30AM	Inogen to Report First Quarter 2025 Financial Results on May 7, 2025 (Business Wire)
07:10AM	Here's Why You Should Retain Inogen Stock in Your Portfolio Now (Zacks)
Mar-27-25 11:30AM	Inogen (INGN) Down 11.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-20-25 08:30AM	Inogen To Present at 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-13-25 09:30AM	Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -5.46%
Feb-26-25 07:41AM	Q4 2024 Inogen Inc Earnings Call (Thomson Reuters StreetEvents) -14.81%
02:17AM	Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... (GuruFocus.com)
Feb-25-25 05:55PM	Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Inogen: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
01:51AM	Inogen Inc (INGN) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-03-25 04:00PM	Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West (Business Wire)
Jan-26-25 12:00PM	Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell (Business Wire)
Jan-24-25 12:00PM	Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Jan-13-25 04:00PM	Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue (Business Wire) +8.17%
Dec-31-24 08:58AM	Inogen Expands U.S. Market with FDA Clearance (TipRanks)
05:20AM	FDA grants clearance for Inogens SIMEOX 200 airway clearance device (Medical Device Network)
Dec-30-24 08:30AM	Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device (Business Wire) +6.18%
Nov-25-24 09:55AM	Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Nov-08-24 08:00PM	Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +17.23%
04:02AM	Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges (GuruFocus.com)
Nov-07-24 06:10PM	Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:05PM	Inogen: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Third Quarter 2024 Financial Results (Business Wire)
04:04PM	Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations (GlobeNewswire)
09:16AM	Inogen, Inc. (INGN): A Bear Case Theory (Insider Monkey)
Nov-06-24 07:43AM	Inogen Inc (INGN) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-24 08:30AM	Inogen to Present at Upcoming Investor Conferences (Business Wire)
Oct-17-24 08:30AM	Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024 (Business Wire)
Oct-09-24 05:09PM	Inogen Inc (INGN) Q2 2024 Earnings Call Highlights: Strong B2B Growth Amid DTC Challenges (GuruFocus.com)
Oct-08-24 08:30AM	Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC (Business Wire)
Sep-05-24 08:30AM	Inogen Appoints Eric Pauls as Vice President of Sales, North America (Business Wire)
Aug-22-24 01:16PM	Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock? (Zacks)
Aug-08-24 12:00PM	Inogen (INGN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +5.32%
Aug-07-24 11:34AM	Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks) +35.95%
Aug-06-24 06:05PM	Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:06PM	Inogen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces Second Quarter 2024 Financial Results (Business Wire)
Jul-22-24 06:24AM	3 Stocks Under $10 With the Potential for Massive Gains (InvestorPlace)
Jul-16-24 08:30AM	Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire) +6.09%
Jul-15-24 09:00AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now (Zacks)
Jul-03-24 04:10PM	Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development (Business Wire) +5.35%
Jun-06-24 11:31AM	Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-03-24 04:05PM	Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio (Business Wire) -5.28%
May-09-24 01:29PM	Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y (Zacks) +5.46%
May-08-24 01:27PM	Inogen, Inc. (NASDAQ:INGN) Q1 2024 Earnings Call Transcript (Insider Monkey) +12.88%
07:14AM	Q1 2024 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Inogen Inc (INGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics with ... (GuruFocus.com)
May-07-24 09:55PM	INGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM	Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings (Zacks)
06:33PM	Inogen Inc (INGN) Q1 2024 Earnings: Navigating Challenges with a Focus on Growth (GuruFocus.com)
05:32PM	Inogen: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Inogen Announces First Quarter 2024 Financial Results (Business Wire)
Apr-10-24 08:30AM	Inogen to Report First Quarter 2024 Financial Results on May 7, 2024 (Business Wire)
Mar-28-24 11:30AM	Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue? (Zacks)
11:26AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
Mar-25-24 08:30AM	Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference (Business Wire) +6.36%
Mar-07-24 04:00PM	Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire) +7.25%
Feb-29-24 08:28AM	Inogen, Inc. (NASDAQ:INGN) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.72%
Feb-28-24 09:22AM	Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves (Zacks) -32.66%
06:47AM	Q4 2023 Inogen Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-24 07:30PM	Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith Kevin P.	EVP, Bus Dev, GC & Sec	Sep 01 '25	Option Exercise	0.00	18,135	0	20,821	Sep 03 05:02 PM
Bourque Michael J.	EVP, CFO & Treasurer	Mar 01 '25	Option Exercise	0.00	25,000	0	25,600	Mar 04 06:42 PM
Bourque Michael J.	EVP, CFO & Treasurer	Mar 03 '25	Buy	8.32	3,000	24,960	47,646	Mar 04 06:42 PM
Smith Kevin Raymond Merrill	CEO and President	Mar 01 '25	Option Exercise	0.00	28,333	0	44,387	Mar 04 06:41 PM
Smith Kevin Raymond Merrill	CEO and President	Mar 03 '25	Buy	8.56	11,709	100,245	70,274	Mar 04 06:41 PM
Smith Kevin Raymond Merrill	CEO and President	Dec 01 '24	Option Exercise	0.00	28,333	0	28,333	Dec 03 05:08 PM
Ramade Gregoire	Chief Commercial Officer	Dec 01 '24	Option Exercise	0.00	31,565	0	31,565	Dec 03 05:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INGN

Inogen Inc

Upgrade your FINVIZ experience